Related Experiment Video
Updated: May 22, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Can apelins guide the diagnosis of coronary artery disease in COPD patients?
Alperen Aksakal1, Buğra Kerget1, Burcu Nur Gülbahar1
1Depertment of Pulmonary Diseases, Ataturk University School of Medicine, Yakutiye, Erzurum, Turkey.
Insights
Serum apelin levels are lower in patients with chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD). Apelin may help diagnose CAD in COPD patients.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Biomarker Discovery
Background:
- Apelin, an adipokine, exhibits anti-inflammatory and antiatherosclerotic properties.
- Apelin is implicated in chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) pathogenesis.
Purpose of the Study:
- To evaluate apelin as a potential biomarker for early diagnosis and management of CAD in COPD patients.
- To investigate the association between serum apelin levels and the presence of CAD in COPD.
Main Methods:
- Serum apelin levels (apelin 12, 13, 17, 36) were measured in 73 stable COPD patients and 35 healthy controls using ELISA.
- COPD patients were stratified into groups with and without CAD.
Main Results:
- Serum apelin levels were significantly lower in COPD patients compared to controls.
- COPD patients with CAD exhibited lower serum apelin levels than those without CAD.
- Apelin 13 and 36 demonstrated high sensitivity and specificity for predicting CAD in COPD patients.
Conclusions:
- Serum apelin, particularly apelin 13 and 36, shows promise as a biomarker for early CAD detection in COPD patients.
- Early diagnosis and management of CAD are crucial for improving prognosis in COPD patients.
Background:
Apelins are adipokines known for their anti-inflammatory, vasodilator, and antiatherosclerotic effects. They are involved in the pathogenesis of chronic diseases like chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD).
Objectives:
This study aims to investigate apelin as a potential biomarker for early diagnosis and management of CAD in COPD patients.
Methods:
The study included 73 stable COPD patients admitted between June 2023 and June 2024 and 35 healthy volunteers matched by age and gender. COPD patients were categorized into two groups: those without CAD (Group 1) and those with CAD (Group 2). Serum levels of apelin 12, 13, 17, and 36 were measured using ELISA.
Results:
Serum apelin levels were significantly lower in COPD patients than in controls (p < 0.001). Among COPD patients, those with CAD showed lower serum apelin levels compared to those without CAD (p = 0.005 for apelin 12, p < 0.001 for apelin 13, 17, and 36). ROC analysis indicated high sensitivity and specificity for apelin 13 and 36 in predicting CAD in COPD patients. Apelin 13 and 36 were positively correlated with ejection fraction (EF) (R = 0.43, p = 0.01; R = 0.4, p = 0.01), and apelin 12 was positively correlated with FEV1 and FVC (R = 0.24, p = 0.04; R = 0.27, p = 0.02).
Conclusion:
While CAD worsens the prognosis in COPD patients, it remains underdiagnosed. Serum apelin, especially apelin 13 and 36, may assist in the early diagnosis and management of CAD in COPD patients.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Assessment of apical pulse
Assessing the apical pulse is a critical nursing procedure, particularly indicated for:
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...